001     6507
005     20200402205709.0
024 7 _ |2 pmid
|a pmid:19583211
024 7 _ |2 DOI
|a 10.1021/bi900901e
024 7 _ |2 WOS
|a WOS:000268720300021
024 7 _ |a altmetric:3455235
|2 altmetric
037 _ _ |a PreJuSER-6507
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biochemistry & Molecular Biology
100 1 _ |0 P:(DE-Juel1)VDB72260
|a Leliveld, S. R.
|b 0
|u FZJ
245 _ _ |a Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C
260 _ _ |a Columbus, Ohio
|b American Chemical Society
|c 2009
300 _ _ |a 7746 - 7755
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |0 798
|a Biochemistry
|v 48
|x 0006-2960
|y 32
500 _ _ |a Funded by a research grant (LE 2197/1-1) to S.R.L. from the German Research Foundation (DFG) and Stanley Medical Research Institute, Baltimore, MD, to C.K.
520 _ _ |a Genetic studies have established a role of disrupted-in-schizophrenia-1 (DISC1) in chronic mental diseases (CMD). Limited experimental data are available on the domain structure of the DISC1 protein although multiple interaction partners are known including a self-association domain within the middle part of DISC1 (residues 403-504). The DISC1 C-terminal domain is deleted in the original Scottish pedigree where DISC1 harbors two coiled-coil domains and disease-associated polymorphisms at 607 and 704, as well as the important nuclear distribution element-like 1 (NDEL1) binding site at residues 802-839. Here, we performed mutagenesis studies of the C-terminal domain of the DISC1 protein (residues 640-854) and analyzed the expressed constructs by biochemical and biophysical methods. We identified novel DISC1 self-association motifs and the necessity of their concerted action for orderly assembly: the region 765-854 comprising a coiled-coil domain is a dimerization domain and the region 668-747 an oligomerization domain; dimerization was found to be a prerequisite for orderly assembly of oligomers. Consistent with this, disease-associated polymorphism C704 displayed a slightly higher oligomerization propensity. The heterogeneity of DISC1 multimers in vitro was confirmed with a monoclonal antibody binding exclusively to HMW multimers. We also identified C-terminal DISC1 fragments in human brains, suggesting that C-terminal fragments could carry out DISC1-dependent functions. When the DISC1 C-terminal domain was transiently expressed in cells, it assembled into a range of soluble and insoluble multimers with distinct fractions selectively binding NDEL1, indicating functionality. Our results suggest that assembly of the C-terminal domain is controlled by distinct domains including the disease-associated polymorphism 704 and is functional in vivo.
536 _ _ |0 G:(DE-Juel1)FUEK409
|2 G:(DE-HGF)
|a Funktion und Dysfunktion des Nervensystems
|c P33
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Animals
650 _ 2 |2 MeSH
|a Antibodies, Monoclonal: metabolism
650 _ 2 |2 MeSH
|a Humans
650 _ 2 |2 MeSH
|a Mice
650 _ 2 |2 MeSH
|a Nerve Tissue Proteins: chemistry
650 _ 2 |2 MeSH
|a Nerve Tissue Proteins: genetics
650 _ 2 |2 MeSH
|a Nerve Tissue Proteins: metabolism
650 _ 2 |2 MeSH
|a Polymorphism, Genetic
650 _ 2 |2 MeSH
|a Protein Multimerization
650 _ 2 |2 MeSH
|a Protein Structure, Quaternary
650 _ 2 |2 MeSH
|a Protein Structure, Tertiary
650 _ 7 |0 0
|2 NLM Chemicals
|a Antibodies, Monoclonal
650 _ 7 |0 0
|2 NLM Chemicals
|a DISC1 protein, human
650 _ 7 |0 0
|2 NLM Chemicals
|a Nerve Tissue Proteins
650 _ 7 |2 WoSType
|a J
700 1 _ |0 P:(DE-HGF)0
|a Hendriks, P.
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Michel, M.
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Sajnani, G.
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Bader, V.
|b 4
700 1 _ |0 P:(DE-HGF)0
|a Trossbach, S.
|b 5
700 1 _ |0 P:(DE-HGF)0
|a Prikulis, I.
|b 6
700 1 _ |0 P:(DE-Juel1)VDB57647
|a Hartmann, R.
|b 7
|u FZJ
700 1 _ |0 P:(DE-Juel1)VDB20019
|a Jonas, E.
|b 8
|u FZJ
700 1 _ |0 P:(DE-Juel1)132029
|a Willbold, D.
|b 9
|u FZJ
700 1 _ |0 P:(DE-HGF)0
|a Requena, J. R.
|b 10
700 1 _ |0 P:(DE-HGF)0
|a Korth, C.
|b 11
773 _ _ |0 PERI:(DE-600)1472258-6
|a 10.1021/bi900901e
|g Vol. 48, p. 7746 - 7755
|p 7746 - 7755
|q 48<7746 - 7755
|t Biochemistry
|v 48
|x 0006-2960
|y 2009
856 7 _ |u http://dx.doi.org/10.1021/bi900901e
909 C O |o oai:juser.fz-juelich.de:6507
|p VDB
913 1 _ |0 G:(DE-Juel1)FUEK409
|a DE-HGF
|b Gesundheit
|k P33
|l Funktion und Dysfunktion des Nervensystems
|v Funktion und Dysfunktion des Nervensystems
|x 0
914 1 _ |y 2010
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |0 I:(DE-Juel1)VDB942
|d 31.12.2010
|g ISB
|k ISB-3
|l Strukturbiochemie
|x 0
970 _ _ |a VDB:(DE-Juel1)114819
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21